SynthesisEuropean journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology2025
Prostate cancer in Nigeria: a scoping review and meta-analysis of current evidence on process indicators and interventions.
Synthesis in European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Burden, clinical characteristics, and management patterns of prostate cancer in Nigeria: a systematic review and meta-analysis.Frontiers in oncology · 2026Pooled it
- Mapping the readiness landscape for prostate cancer screening in Europe: analysis of health system capacity across the PRAISE-U pilots.EClinicalMedicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
introductionDespite Nigeria's high prostate cancer burden, data remain fragmented due to systemic challenges. This scoping review aims to comprehensively synthesize existing evidence on epidemiological and clinical process indicators during prostate cancer detection and management, and to provide insights on the status of prostate cancer interventions in order to guide informed practice and support policy decisions.
methodsThe Embase, PubMed, and Web of Science databases were searched for journal articles published in English from 2020 to 2024. Studies were included if they captured thematic areas on process indicators and intervention mapping concepts. Covidence® and Mendeley software were used for data screening, a Microsoft Excel Spreadsheet template for data charting and summarization, and Stata software for meta-analysis.
resultsA total of 448 articles were screened, and 48 were included. The majority of the retrieved studies, 83.3 % (n = 40), had an observational study design. Studies on screening and diagnosis (11 studies, 22.9 %) dominated thematic area on the concepts of interest related to process indicators. Studies on intervention tools and markers (14 studies, 29.2 %) dominated thematic areas on the concepts of interest related to intervention mapping, and none of the studies reported implementation outcomes.
conclusionsThis research has provided baseline values of multiple process indicators that can be used as reference points to evaluate progress during prostate cancer detection and management interventions. It has also highlighted a limited number of studies on intervention implementation, therefore, underscoring the critical need for system-level and translational health services research to support health systems strengthening.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.